iiinova — where your digital self keeps evolving

Rod Ritchie @malefitness.bsky.social · 09/04/2025

Bluesky’s Quest to Build Nontoxic Social Media

Rod Ritchie @malefitness.bsky.social · 31/03/2025

A PLEA TO RAISE THE BAR ON PATIENT COMMUNICATIONS The author describes how healthcare workers failed to understand patient vulnerability and exercise basic human rights during a simple procedure. nohalfmeasures.blog/2025/03/31/n...

nohalfmeasures.blog

Navigating Patient Vulnerability During Medical Procedures

Recently, I had my ninth (9th) procedure since my Stage IV Metastatic Breast Cancer (MBC) diagnosis in 2017; it was the third procedure involving a port and the sixth (6th) or maybe seventh (7th) l…

020

Rod Ritchie @malefitness.bsky.social · 25/03/2025

My colleague and friend Bob Riter makes no distinction between cancers and ditto between genders when it comes to advocacy. “Having had both breast cancer and prostate cancer, I can’t help but compare the two of them. They are biologically similar in many ways…” www.lbbc.org/blog/making-...

lbbc.org

Making the most of cancer: My journey from diagnosis to advocate | LBBC

Discover Bob Riter's journey from male breast cancer and prostate cancer to lifelong advocacy. Learn how a CHEK2 mutation shaped his path and what genetic testing means for cancer care.

010

Rod Ritchie @malefitness.bsky.social · 05/03/2025

POOR TASTE “The Novartis ad may have sparked conversation, but it’s time for all of us to think beyond the spectacle and focus on what truly matters: the real-world impact of breast cancer and the fight for equitable care and resources for all those affected.” nohalfmeasures.blog/2025/02/17/s...

nohalfmeasures.blog

Sexualizing Breast Cancer = Everyone Loses

The author critiques Super Bowl commercials by Novartis and Pfizer for their insensitivity towards patients suffering from breast cancer. She argues these ads sexualize a serious illness, neglect m…

000

Rod Ritchie @malefitness.bsky.social · 17/02/2025

CLUMSY SUPERBOWL MESSAGING “The commercial ignored all of these people and could have made it even harder for men to have their concerns addressed -- if people are only focusing on the young, bouncing breasts, it sidelines everyone else, the people who need help.” nohalfmeasures.blog

nohalfmeasures.blog

No Half Measures

Living Out Loud with Metastatic Breast Cancer

020

Rod Ritchie @malefitness.bsky.social · 28/12/2024

“Men with breast cancer are often left to fight the disease in silence. This silence has led to psychological and emotional distress in conjunction with illness-related stigmas.” www.oncnursingnews.com/view/looking...

oncnursingnews.com

Looking More Closely at Breast Cancer in Male Patients

Although breast cancer has historically been associated with female patients, the rates of men with breast cancer have been increasing over the past decade.

052

Rod Ritchie @malefitness.bsky.social · 09/12/2024

MALE BREAST CANCER POSTERS SABCS 2024 Compiled by Rod Ritchie, President, Board of Directors, Male Breast Cancer Global Alliance 9 December 2024 malebc.org/wp-content/u...

malebc.org

1166

Rod Ritchie @malefitness.bsky.social · 21/11/2024

“Although the disease is the same, men undergoing treatment for breast cancer face a unique set of challenges, both physical and emotional. As a breast cancer survivor, here are my experiences:” preventcancer.org/article/male...

preventcancer.org

Overcoming the stigma of male breast cancer

As a breast cancer survivor, here are my experiences. The lack of awareness made it difficult to find information and support.

1264

Rod Ritchie @malefitness.bsky.social · 20/11/2024

“Public-health officials wonder if they have sufficient clout for the next national emergency. “Science is losing its place as a source of truth,” said Dr. Paul Offit, an infectious-disease physician.” How Science Lost America’s Trust and Surrendered Health Policy to Skeptics

0113

Rod Ritchie @malefitness.bsky.social · 19/11/2024

Which patients with early-stage breast cancer will benefit most from immunotherapy, and at what point is immunotherapy most useful? This question spans neoadjuvant and adjuvant settings. www.medscape.com/viewarticle/...

medscape.com

When or Whether to Give Immunotherapy in Early Breast Cancer

Neoadjuvant immunotherapy offers a survival benefit in specific subtypes of patients but seems to offer no benefit in the adjuvant setting.

051

Reposted by Rod Ritchie

Stacey Tinianov, MPH @coffeemommy.bsky.social · 11/11/2024

Okay, after tutelage from @joshuajfriedman.com via @megamidevice.bsky.social (THANK YOU!), I've turned my Oncology Advocates & Allies list into a Starter Pack. If I missed you (or your weren't here yet, let me know below and I'll add you) #MedSky #bcsm #crcsm #gyncsm #lcsm #mmsm go.bsky.app/2CrWvVs

294613